Tilton John 4

4 · Biohaven Pharmaceutical Holding Co Ltd. · Filed Jan 7, 2022

Form 4

Period: 2022-01-06

Chief Commercial Officer

Transactions

Tax Payment
Common Shares
2022-01-06$123.86/sh−551$68,247→ 4,404 total
Exercise/Conversion
Common Shares
2022-01-07+875→ 5,279 total
Tax Payment
Common Shares
2022-01-07$128.87/sh−342$44,074→ 4,937 total
Exercise/Conversion
Restricted Share Unit Award
2022-01-06−1,250→ 2,500 total
→ Common Shares (1,250 underlying)
Award
Employee Stock Option (right to buy)
2022-01-07+7,000→ 7,000 total
Exercise: $128.87Exp: 2032-01-07→ Common Shares (7,000 underlying)
Award
Restricted Share Unit Award
2022-01-07+3,500→ 3,500 total
→ Common Shares (3,500 underlying)
Exercise/Conversion
Restricted Share Unit Award
2022-01-07−875→ 2,625 total
→ Common Shares (875 underlying)
Exercise/Conversion
Common Shares
2022-01-06+1,250→ 4,955 total

Holdings

Footnotes (7)

[F1]This balance includes 271 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2021, and 17 shares that were acquired through the Biohaven Employee Share Purchase Plan on November 30, 2021.
[F2]No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
[F3]Each restricted share unit represents the contingent right to receive one common share of the Issuer.
[F4]The reporting person was granted 5,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date.
[F5]Not applicable.
[F6]The shares underlying this option vest in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service with the Issuer at each vesting date.
[F7]The reporting person was granted 3,500 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date.

Documents

2 files